{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:32:05Z","timestamp":1793388725004,"version":"4.5.0"},"reference-count":41,"publisher":"American Chemical Society (ACS)","issue":"20","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/100016958","name":"Office of Research Infrastructure Programs","doi-asserted-by":"publisher","award":["S10OD030472"],"award-info":[{"award-number":["S10OD030472"]}],"id":[{"id":"10.13039\/100016958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA076292"],"award-info":[{"award-number":["P30-CA076292"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA262530"],"award-info":[{"award-number":["R01CA262530"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Selective targeting of ULK1 represents a promising approach to overcome autophagy-mediated resistance in KRAS-driven cancers. However, achieving selectivity over the closely related ULK2 isoform with ATP-competitive inhibitors remains challenging due to the high sequence homology within their kinase domains. Here, we describe the design, synthesis, and structure\u2212degradation relationship studies of two cereblon-recruiting ULK1 degraders, MR-9034 and MR-9036. Structure-guided optimization led to the discovery of MR-9036 as a potent and selective ULK1 PROTAC that degrades ULK1 without affecting ULK2 or IMiD neo-substrates. Cellular and biophysical studies confirm ternary complex formation and proteasome-dependent degradation. Compared with the clinical ULK1\/2 inhibitor DCC-3116, MR-9036 produces sustained autophagy suppression following compound washout. In KRASG12C-mutant NSCLC models, ULK1 degradation enhances the antiproliferative activity of sotorasib. Pharmacokinetic\/pharmacodynamic (PK\/PD) studies in mice support in vivo feasibility. These findings establish selective ULK1 degradation as a chemical strategy to interrogate ULK1 biology and enhance therapeutic response in KRAS-driven cancers.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.6c01340","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:02:38Z","timestamp":1791388958000},"page":"23744-23769","source":"Crossref","is-referenced-by-count":0,"title":["Discovery and Optimization of Isoform Selective ULK1 Degraders to Enhance Antitumor Activity in KRAS-Mutant Cancer"],"prefix":"10.1021","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1768-5125","authenticated-orcid":true,"given":"Sean","family":"Chin Chan","sequence":"first","affiliation":[{"name":"H. Lee Moffitt Cancer Center and Research Institute , , , ,","place":["Tampa, Florida, United States, 33612"]},{"name":"University of South Florida\/H. Lee Moffitt Cancer Center and Research Institute , , , ,","place":["Tampa, Florida, United States, 33620"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Bayle","sequence":"additional","affiliation":[{"name":"H. Lee Moffitt Cancer Center and Research Institute , , , ,","place":["Tampa, Florida, United States, 33612"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micheal","family":"Lamptey","sequence":"additional","affiliation":[{"name":"H. Lee Moffitt Cancer Center and Research Institute , , , ,","place":["Tampa, Florida, United States, 33612"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1576-5073","authenticated-orcid":true,"given":"Ansar","family":"Lee-Sam","sequence":"additional","affiliation":[{"name":"H. Lee Moffitt Cancer Center and Research Institute , , , ,","place":["Tampa, Florida, United States, 33612"]},{"name":"University of South Florida\/H. Lee Moffitt Cancer Center and Research Institute , , , ,","place":["Tampa, Florida, United States, 33620"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5260-4664","authenticated-orcid":true,"given":"Luxin","family":"Sun","sequence":"additional","affiliation":[{"name":"H. Lee Moffitt Cancer Center and Research Institute , , , ,","place":["Tampa, Florida, United States, 33612"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5472-7289","authenticated-orcid":true,"given":"Dylan","family":"Grassie","sequence":"additional","affiliation":[{"name":"H. Lee Moffitt Cancer Center and Research Institute , , , ,","place":["Tampa, Florida, United States, 33612"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramu","family":"Kakumanu","sequence":"additional","affiliation":[{"name":"H. Lee Moffitt Cancer Center and Research Institute , , , ,","place":["Tampa, Florida, United States, 33612"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer","family":"Sansil","sequence":"additional","affiliation":[{"name":"H. Lee Moffitt Cancer Center and Research Institute , , , ,","place":["Tampa, Florida, United States, 33612"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3589-3510","authenticated-orcid":true,"given":"Ernst","family":"Scho\u0308nbrunn","sequence":"additional","affiliation":[{"name":"H. Lee Moffitt Cancer Center and Research Institute , , , ,","place":["Tampa, Florida, United States, 33612"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek R.","family":"Duckett","sequence":"additional","affiliation":[{"name":"H. Lee Moffitt Cancer Center and Research Institute , , , ,","place":["Tampa, Florida, United States, 33612"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1145-1822","authenticated-orcid":true,"given":"Andrii","family":"Monastyrskyi","sequence":"additional","affiliation":[{"name":"H. Lee Moffitt Cancer Center and Research Institute , , , ,","place":["Tampa, Florida, United States, 33612"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"issue":"1","key":"2026103015070738200_cit1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10059-013-0140-8","article-title":"Autophagy: a critical regulator of cellular metabolism and homeostasis","volume":"36","author":"Ryter","year":"2013","journal-title":"Mol. Cells"},{"issue":"2","key":"2026103015070738200_cit2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.molcel.2010.09.023","article-title":"Autophagy and the integrated stress response","volume":"40","author":"Kroemer","year":"2010","journal-title":"Mol. Cell"},{"issue":"6","key":"2026103015070738200_cit3","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/s41591-020-0947-8","article-title":"Author Correction: Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer","volume":"26","author":"Bryant","year":"2020","journal-title":"Nat. Med."},{"issue":"2","key":"2026103015070738200_cit4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/path.4354","article-title":"An activation of LC3A-mediated autophagy contributes to de novo and acquired resistance to EGFR tyrosine kinase inhibitors in lung adenocarcinoma","volume":"234","author":"Nihira","year":"2014","journal-title":"J. Pathol."},{"issue":"3","key":"2026103015070738200_cit5","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.lungcan.2013.05.012","article-title":"Erlotinib-induced autophagy in epidermal growth factor receptor mutated non-small cell lung cancer","volume":"81","author":"Li","year":"2013","journal-title":"Lung Cancer"},{"issue":"6","key":"2026103015070738200_cit6","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/jto.0b013e31828c7210","article-title":"The autophagy inhibitor chloroquine overcomes the innate resistance of wild-type EGFR non-small-cell lung cancer cells to erlotinib","volume":"8","author":"Zou","year":"2013","journal-title":"J. Thorac. Oncol."},{"issue":"5","key":"2026103015070738200_cit7","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/s41591-019-0433-3","article-title":"Publisher Correction: Protective autophagy elicited by RAF\u2192MEK\u2192ERK inhibition suggests a treatment strategy for RAS-driven cancers","volume":"25","author":"Kinsey","year":"2019","journal-title":"Nat. Med."},{"issue":"7","key":"2026103015070738200_cit8","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1091\/mbc.e08-12-1249","article-title":"ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery","volume":"20","author":"Jung","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"2026103015070738200_cit9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.isci.2018.09.012","article-title":"A Potent and Selective ULK1 Inhibitor Suppresses Autophagy and Sensitizes Cancer Cells to Nutrient Stress","volume":"8","author":"Martin","year":"2018","journal-title":"iScience"},{"key":"2026103015070738200_cit10","doi-asserted-by":"publisher","first-page":"116101","DOI":"10.1016\/j.ejmech.2023.116101","article-title":"Development of potent and selective ULK1\/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties","volume":"266","author":"Morozova","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"23","key":"2026103015070738200_cit11","doi-asserted-by":"publisher","first-page":"14609","DOI":"10.1021\/acs.jmedchem.0c00873","article-title":"Design, Synthesis, and Characterization of an Orally Active Dual-Specific ULK1\/2 Autophagy Inhibitor that Synergizes with the PARP Inhibitor Olaparib for the Treatment of Triple-Negative Breast Cancer","volume":"63","author":"Ren","year":"2020","journal-title":"J. Med. Chem."},{"key":"2026103015070738200_cit12","unstructured":"Gonzalez-Lopez, M.; Vernier, J.-M.\n          Macrocyclic ULK1\/2 Inhibitors and Their Use Thereof. WO 2024233766 A1, 2024."},{"issue":"18","key":"2026103015070738200_cit13","doi-asserted-by":"publisher","first-page":"12297","DOI":"10.1074\/jbc.m900573200","article-title":"ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy","volume":"284","author":"Ganley","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"6","key":"2026103015070738200_cit14","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1042\/ebc20170021","article-title":"The mammalian ULK1 complex and autophagy initiation","volume":"61","author":"Zachari","year":"2017","journal-title":"Essays Biochem."},{"issue":"5","key":"2026103015070738200_cit15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.4161\/auto.5.5.8249","article-title":"A novel, human Atg13 binding protein, Atg101, interacts with ULK1 and is essential for macroautophagy","volume":"5","author":"Mercer","year":"2009","journal-title":"Autophagy"},{"issue":"1","key":"2026103015070738200_cit16","doi-asserted-by":"publisher","first-page":"14874","DOI":"10.1038\/s41598-020-71527-4","article-title":"A pan-cancer assessment of alterations of the kinase domain of ULK1, an upstream regulator of autophagy","volume":"10","author":"Kumar","year":"2020","journal-title":"Sci. Rep."},{"issue":"7","key":"2026103015070738200_cit17","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/ncb2757","article-title":"ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase","volume":"15","author":"Russell","year":"2013","journal-title":"Nat. Cell Biol."},{"issue":"35","key":"2026103015070738200_cit18","doi-asserted-by":"publisher","first-page":"25464","DOI":"10.1074\/jbc.m703663200","article-title":"siRNA screening of the kinome identifies ULK1 as a multidomain modulator of autophagy","volume":"282","author":"Chan","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"1","key":"2026103015070738200_cit19","doi-asserted-by":"publisher","first-page":"10940","DOI":"10.1038\/s41598-020-67780-2","article-title":"ULK1 and ULK2 are less redundant than previously thought: computational analysis uncovers distinct regulation and functions of these autophagy induction proteins","volume":"10","author":"Demeter","year":"2020","journal-title":"Sci. Rep."},{"issue":"7","key":"2026103015070738200_cit20","doi-asserted-by":"publisher","first-page":"689","DOI":"10.4161\/auto.7.7.15450","article-title":"The requirement of uncoordinated 51-like kinase 1 (ULK1) and ULK2 in the regulation of autophagy","volume":"7","author":"Lee","year":"2011","journal-title":"Autophagy"},{"issue":"5","key":"2026103015070738200_cit21","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nchembio.2329","article-title":"Structural basis of PROTAC cooperative recognition for selective protein degradation","volume":"13","author":"Gadd","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"7","key":"2026103015070738200_cit22","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41589-018-0055-y","article-title":"Plasticity in binding confers selectivity in ligand-induced protein degradation","volume":"14","author":"Nowak","year":"2018","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"2026103015070738200_cit23","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.chembiol.2018.11.006","article-title":"Homolog-Selective Degradation as a Strategy to Probe the Function of CDK6 in AML","volume":"26","author":"Brand","year":"2019","journal-title":"Cell Chem. Biol."},{"issue":"1","key":"2026103015070738200_cit24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s42003-020-0868-6","article-title":"Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2","volume":"3","author":"Mares","year":"2020","journal-title":"Commun. Biol."},{"issue":"43","key":"2026103015070738200_cit25","doi-asserted-by":"publisher","first-page":"23327","DOI":"10.1002\/anie.202109237","article-title":"Discovery and Characterisation of Highly Cooperative FAK-Degrading PROTACs","volume":"60","author":"Law","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"issue":"7","key":"2026103015070738200_cit26","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41568-025-00817-8","article-title":"Targeted protein degradation for cancer therapy","volume":"25","author":"Hinterndorfer","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"15","key":"2026103015070738200_cit27","doi-asserted-by":"publisher","first-page":"8554","DOI":"10.1073\/pnas.141230798","article-title":"Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation","volume":"98","author":"Sakamoto","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2026103015070738200_cit28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41392-019-0101-6","article-title":"PROTACs: great opportunities for academia and industry","volume":"4","author":"Sun","year":"2019","journal-title":"Signal Transduct. Targeted Ther."},{"key":"2026103015070738200_cit29","doi-asserted-by":"publisher","first-page":"118253","DOI":"10.1016\/j.ejmech.2025.118253","article-title":"A double-edged sword of neo-substrate degradation in PROTACs","volume":"301","author":"Song","year":"2026","journal-title":"Eur. J. Med. Chem."},{"issue":"6168","key":"2026103015070738200_cit30","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1126\/science.1244851","article-title":"Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells","volume":"343","author":"Kronke","year":"2014","journal-title":"Science"},{"issue":"7597","key":"2026103015070738200_cit31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/nature16979","article-title":"Structural basis of lenalidomide-induced CK1alpha degradation by the CRL4(CRBN) ubiquitin ligase","volume":"532","author":"Petzold","year":"2016","journal-title":"Nature"},{"issue":"13","key":"2026103015070738200_cit32","doi-asserted-by":"publisher","first-page":"13169","DOI":"10.1021\/acs.jmedchem.5c00783","article-title":"Research Progress in Targeting GSPT1: Molecular Glues, Bifunctional Degraders, and Antibody-Enabled Molecular Glues for Cancer Therapy","volume":"68","author":"Cheng","year":"2025","journal-title":"J. Med. Chem."},{"issue":"10","key":"2026103015070738200_cit33","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/s41589-018-0129-x","article-title":"SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate","volume":"14","author":"Matyskiela","year":"2018","journal-title":"Nat. Chem. Biol."},{"issue":"9","key":"2026103015070738200_cit34","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00018-010-0619-9","article-title":"Teratogenic effects of thalidomide: molecular mechanisms","volume":"68","author":"Ito","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"issue":"6715","key":"2026103015070738200_cit35","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1126\/science.adm8684","article-title":"Targeting cancer with small-molecule pan-KRAS degraders","volume":"385","author":"Popow","year":"2024","journal-title":"Science"},{"issue":"3","key":"2026103015070738200_cit36","doi-asserted-by":"publisher","DOI":"10.1080\/23723556.2015.1061097","article-title":"p32: A new player in autophagy","volume":"3","author":"Jiao","year":"2016","journal-title":"Mol. Cell. Oncol."},{"key":"2026103015070738200_cit37","doi-asserted-by":"publisher","DOI":"10.7554\/elife.96992","article-title":"Inhibition of ULK1\/2 and KRAS(G12C) controls tumor growth in preclinical models of lung cancer","volume":"13","author":"Ghazi","year":"2024","journal-title":"eLife"},{"key":"2026103015070738200_cit38","unstructured":"Flynn, D. L.; Ahn, Y. M.; Caldwell, T.; Vogeti, L.\n          Phenylaminopyrimidine amide autophagy, autophagy inhibitors and methods of use thereof. U.S. Patent 20,200,354,352 Al, 2020."},{"issue":"1","key":"2026103015070738200_cit39","doi-asserted-by":"publisher","first-page":"8885","DOI":"10.1038\/s41467-024-52871-9","article-title":"Design of a Cereblon construct for crystallographic and biophysical studies of protein degraders","volume":"15","author":"Kroupova","year":"2024","journal-title":"Nat. Commun."},{"key":"2026103015070738200_cit40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2105-14-153","article-title":"Iterative rank-order normalization of gene expression microarray data","volume":"14","author":"Welsh","year":"2013","journal-title":"BMC Bioinf."},{"issue":"7","key":"2026103015070738200_cit41","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6c01340","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/20\/23744\/68777513\/jm6c01340.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/20\/23744\/68777513\/jm6c01340.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:11:56Z","timestamp":1793387516000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/69\/20\/23744\/5446499\/Discovery-and-Optimization-of-Isoform-Selective"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":41,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2026,10,7]]},"published-print":{"date-parts":[[2026,10,22]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c01340","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]}}}